Risk Factors for Metachronous Gastric Neoplasms in Patients Who Underwent Endoscopic Resection of a Gastric Neoplasm

키워드

참고문헌 (35)

1. Nakajima T, "Metachronous gastric cancers after endoscopic resection: how effective is annual endoscopic surveillance?", Gastric Cancer, 9, pp.93~98 (2006)
2. Kato M, "Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group", Gut, 62, pp.1425~1432 (2013)
3. Hanaoka N, "Autofluorescence imaging for predicting development of metachronous gastric cancer after Helicobacter pylori eradication", J Gastroenterol Hepatol, 25, pp.1844~1849 (2010)
4. Watari J, "Biomarkers predicting development of metachronous gastric cancer after endoscopic resection:an analysis of molecular pathology of Helicobacter pylori eradication", Int J Cancer, 130, pp.2349~2358 (2012)
5. Kim YI, "The association between Helicobacter pylori status and incidence of metachronous gastric cancer after endoscopic resection of early gastric cancer", Helicobacter, 19, pp.194~201 (2014)
6. Ushijima T, "Molecular pathways: involvement of Helicobacter pylori-triggered inflammation in the formation of an epigenetic field defect, and its usefulness as cancer risk and exposure markers", Clin Cancer Res, 18, pp.923~929 (2012)
7. Chiba T, "Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation", Gastroenterology, 143, pp.550~563 (2012)
8. Graham DY, "Helicobacter pylori eradication and metachronous gastric cancer", Clin Gastroenterol Hepatol, 12, pp.801~803 (2014)
9. Yoon H, "Effect of endoscopic screening at 1-year intervals on the clinicopathologic characteristics and treatment of gastric cancer in South Korea", J Gastroenterol Hepatol, 27, pp.928~934 (2012)
10. Shin CM, "Role of Helicobacter pylori infection in aberrant DNA methylation along multistep gastric carcinogenesis", Cancer Sci, 101, pp.1337~1346 (2010)
11. Shin CM, "Genome-wide DNA methylation profiles in noncancerous gastric mucosae with regard to Helicobacter pylori infection and the presence of gastric cancer", Helicobacter, 16, pp.179~188 (2011)
12. Shin CM, "Prediction of the risk for gastric cancer using candidate methylation markers in the non-neoplastic gastric mucosae", J Pathol, 226, pp.654~665 (2012)
13. Shin CM, "Changes in aberrant DNA methylation after Helicobacter pylori eradication: a long-term follow-up study", Int J Cancer, 133, pp.2034~2042 (2013)
14. Soetikno R, "Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract", J Clin Oncol, 23, pp.4490~4498 (2005)
15. Shin CM, "Validation of diagnostic tests for Helicobacter pylori with regard to grade of atrophic gastritis and", or intestinal metaplasia, 2009, pp.14, 512~519
16. Yoon H, "Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics", Helicobacter, 16, pp.382~388 (2011)
17. Miki K, "The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects", Jpn J Cancer Res, 80, pp.111~114 (1989)
18. Dixon MF, "Classification and grading of gastritis: the updated Sydney System. International workshop on the histopathology of gastritis, Houston 1994", Am J Surg Pathol, 20, pp.1161~1181 (1996)
19. Yoon H, "Risk factors of residual or recurrent tumor in patients with a tumor-positive resection margin after endoscopic resection of early gastric cancer", Surg Endosc, 27, pp.1561~1568 (2013)
20. Herman JG, "Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands", Proc Natl Acad Sci U S A, 93, pp.9821~9826 (1996)
21. Leung WK, "Review article: intestinal metaplasia and gastric carcinogenesis", Aliment Pharmacol Ther, 16, pp.1209~1216 (2002)
22. Kim N, "Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up", J Clin Gastroenterol, 42, pp.448~454 (2008)
23. You WC, "Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer", Int J Cancer, 83, pp.615~619 (1999)
24. Cassaro M, "Topographic patterns of intestinal metaplasia and gastric cancer", Am J Gastroenterol, 95, pp.1431~1438 (2000)
25. Bae SE, "Effect of Helicobacter pylori eradication on metachronous recurrence after endoscopic resection of gastric neoplasm", Am J Gastroenterol, 109, pp.60~67 (2014)
26. 장미영, "Clinicopathological characteristics of synchronous and metachronous gastric neoplasms after endoscopic submucosal dissection", The Korean Journal of Internal Medicine, 28(6), pp.687~693 (2013), 대한내과학회[DOI]
27. Han JS, "A study of metachronous cancer after endoscopic resection of early gastric cancer", Scand J Gastroenterol, 46, pp.1099~1104 (2011)
28. Kim N, "Prevalence and risk factors of atrophic gastritis and intestinal metaplasia in a Korean population without significant gastroduodenal disease", Helicobacter, 13, pp.245~255 (2008)
29. Lee IS, "Multiple synchronous early gastric cancers: high-risk group and proper management", Surg Oncol, 21, pp.269~273 (2012)
30. Shin CM, "Stomach cancer risk in gastric cancer relatives: interaction between Helicobacter pylori infection and family history of gastric cancer for the risk of stomach cancer", J Clin Gastroenterol, 44, pp.e34~e39 (2010)
31. Brenner H, "Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma", Cancer, 88, pp.274~279 (2000)
32. Eshmuratov A, "The correlation of endoscopic and histological diagnosis of gastric atrophy", Dig Dis Sci, 55, pp.1364~1375 (2010)
33. Toshikazu Ushijima, "Epigenetic Field for Cancerization", BMB reports, 40(2), pp.142~150 (2007), 한국생화학분자생물학회
34. 강정묵, "CDX1 and CDX2 Expression in Intestinal Metaplasia, Dysplasia and Gastric Cancer", Journal of Korean Medical Science, 26(5), pp.647~653 (2011), 대한의학회
35. Byoung Hwan Lee, "The Role of CDX2 in Intestinal Metaplasia Evaluated Using Immunohistochemistry", Gut and Liver, 6(1), pp.71~77 (2012), 거트앤리버 발행위원회

관련 논문AI추천